Latest / Stock Movers / Intel Falls, Dynavax Climbs, Snowflake Slides
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market
- 0:13Speaker 1: harnessing the power of Bloomberg Data. Let's take a look at.
- 0:17Speaker 2: Some of the stocks on the move today. We can
- 0:18Speaker 2: do that with bloom Work Equities reported Natalia Canandiavi Natali.
- 0:22Speaker 2: What are you looking at? Let's start with Intel. The
- 0:23Speaker 2: ticker is i NTC. The shares are down by almost
- 0:27Speaker 2: two percent. So it came after Reuters reported that n
- 0:30Speaker 2: Video holded test that uses Intel's eighteen eight technology to
- 0:37Speaker 2: produce its chips. We know that recently, and Video reported
- 0:40Speaker 2: that it tested actually if it could manufacture its own
- 0:45Speaker 2: chips using this eighteen A production technology. Reuters cited people
- 0:49Speaker 2: familiar with the matter. As of now, both companies did
- 0:53Speaker 2: not comment on that. And it's been really critical for
- 0:57Speaker 2: Intel's turnaround stories. Investors really want to see if this
- 1:01Speaker 2: story can play out and then we know. In September,
- 1:04Speaker 2: Nvidia agreed to invest about five billion dollars in Intel
- 1:08Speaker 2: and said that it will code develop chips for PCs
- 1:13Speaker 2: and data centers using its technology.
- 1:16Speaker 1: All right, well, it's really all about the versification of
- 1:18Speaker 1: chip supply now, right, and Nvidia definitely be challenged in
- 1:21Speaker 1: that space.
- 1:22Speaker 2: Right, Let's take a look at another stock. You're looking at.
- 1:24Speaker 2: Dinavacs tells about that exactly. So the ticker's dvax shares
- 1:28Speaker 2: are up by thirty eight percent. It came after Sanofi,
- 1:32Speaker 2: which is a French pharmaceutical company, said that it will
- 1:36Speaker 2: start a cash tender to offer to acquire all outstanding
- 1:39Speaker 2: shares a vaccine maker for fifteen point fifty dollars per share.
- 1:44Speaker 2: Sanofie agreed to buy Dynavags for about two point two
- 1:47Speaker 2: billion dollars. This deal gives Sanofi access to some vaccines,
- 1:52Speaker 2: including hepatitis B vaccines. And we know that this is
- 1:56Speaker 2: also quite a crucial deal for Sanofi because it's struggling
- 1:59Speaker 2: also to increase performance and to boost its revenue as
- 2:05Speaker 2: we see lots of challenges in global vaccine market. All right,
- 2:09Speaker 2: one more, what do you have for us here? It
- 2:11Speaker 2: is Snowflake. The tickery snow shares are down by two
- 2:15Speaker 2: point three percent today. It came after the Information reported
- 2:19Speaker 2: that the software company is in conversations to buy a
- 2:22Speaker 2: startup called Observe for about one billion dollars. So Observe,
- 2:28Speaker 2: this is a startup based in California, and it develops
- 2:33Speaker 2: the so called observatory tools that help developers to track
- 2:37Speaker 2: how the apps perform or if there are any challenges
- 2:40Speaker 2: on the software side. And analysts are really excited actually
- 2:45Speaker 2: about this potential deal because they say it will allow
- 2:49Speaker 2: the company to compete more closely with companies like Data Bricks,
- 2:53Speaker 2: So for now it is a pretty solid move. However,
- 2:56Speaker 2: of course, shares are down fade.
- 2:59Speaker 1: The stockmover's report from Bloomberg Radio. Check back with us
- 3:03Speaker 1: throughout the day for the latest roundup of companies making
- 3:06Speaker 1: news on Wall Street and for the latest market moving headlines.
- 3:10Speaker 1: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 3:14Speaker 1: dot com, and on Applecarplay and Android Auto with the
- 3:17Speaker 1: Bloomberg Business app.